nodes	percent_of_prediction	percent_of_DWPC	metapath
Naphazoline—Intraocular pressure increased—Tiotropium—chronic obstructive pulmonary disease	0.0541	0.0813	CcSEcCtD
Naphazoline—Intraocular pressure increased—Prednisolone—chronic obstructive pulmonary disease	0.0236	0.0355	CcSEcCtD
Naphazoline—Mydriasis—Salbutamol—chronic obstructive pulmonary disease	0.0227	0.0342	CcSEcCtD
Naphazoline—Intraocular pressure increased—Prednisone—chronic obstructive pulmonary disease	0.0172	0.0258	CcSEcCtD
Naphazoline—Tension—Roflumilast—chronic obstructive pulmonary disease	0.0162	0.0244	CcSEcCtD
Naphazoline—Nervousness—Roflumilast—chronic obstructive pulmonary disease	0.0161	0.0241	CcSEcCtD
Naphazoline—Keratitis—Prednisolone—chronic obstructive pulmonary disease	0.016	0.0241	CcSEcCtD
Naphazoline—Endophthalmitis—Prednisone—chronic obstructive pulmonary disease	0.0159	0.0239	CcSEcCtD
Naphazoline—Hyperglycaemia—Aminophylline—chronic obstructive pulmonary disease	0.0143	0.0215	CcSEcCtD
Naphazoline—Discomfort—Roflumilast—chronic obstructive pulmonary disease	0.0139	0.0209	CcSEcCtD
Naphazoline—Hyperglycaemia—Tiotropium—chronic obstructive pulmonary disease	0.0135	0.0202	CcSEcCtD
Naphazoline—Mydriasis—Prednisolone—chronic obstructive pulmonary disease	0.013	0.0196	CcSEcCtD
Naphazoline—Terbinafine—CYP1A2—chronic obstructive pulmonary disease	0.0124	0.225	CrCbGaD
Naphazoline—Eye disorder—Tiotropium—chronic obstructive pulmonary disease	0.0112	0.0168	CcSEcCtD
Naphazoline—Hyperglycaemia—Arformoterol—chronic obstructive pulmonary disease	0.0109	0.0163	CcSEcCtD
Naphazoline—Hyperglycaemia—Formoterol—chronic obstructive pulmonary disease	0.0109	0.0163	CcSEcCtD
Naphazoline—Tension—Aminophylline—chronic obstructive pulmonary disease	0.0108	0.0163	CcSEcCtD
Naphazoline—Nervousness—Aminophylline—chronic obstructive pulmonary disease	0.0107	0.0161	CcSEcCtD
Naphazoline—Drowsiness—Montelukast—chronic obstructive pulmonary disease	0.0105	0.0158	CcSEcCtD
Naphazoline—Hyperglycaemia—Salbutamol—chronic obstructive pulmonary disease	0.0103	0.0154	CcSEcCtD
Naphazoline—Duloxetine—SLC6A4—chronic obstructive pulmonary disease	0.0102	0.187	CrCbGaD
Naphazoline—Drowsiness—Salbutamol—chronic obstructive pulmonary disease	0.0101	0.0152	CcSEcCtD
Naphazoline—Vision blurred—Tiotropium—chronic obstructive pulmonary disease	0.0098	0.0147	CcSEcCtD
Naphazoline—Sweating—Salbutamol—chronic obstructive pulmonary disease	0.00972	0.0146	CcSEcCtD
Naphazoline—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.00968	0.0146	CcSEcCtD
Naphazoline—Duloxetine—CYP1A2—chronic obstructive pulmonary disease	0.00933	0.17	CrCbGaD
Naphazoline—Hypertension—Tiotropium—chronic obstructive pulmonary disease	0.00898	0.0135	CcSEcCtD
Naphazoline—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00892	0.0134	CcSEcCtD
Naphazoline—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00845	0.0127	CcSEcCtD
Naphazoline—Tension—Arformoterol—chronic obstructive pulmonary disease	0.00823	0.0124	CcSEcCtD
Naphazoline—Tension—Formoterol—chronic obstructive pulmonary disease	0.00823	0.0124	CcSEcCtD
Naphazoline—Nervousness—Formoterol—chronic obstructive pulmonary disease	0.00815	0.0123	CcSEcCtD
Naphazoline—Nervousness—Arformoterol—chronic obstructive pulmonary disease	0.00815	0.0123	CcSEcCtD
Naphazoline—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00801	0.012	CcSEcCtD
Naphazoline—Duloxetine—HTR2A—chronic obstructive pulmonary disease	0.00787	0.143	CrCbGaD
Naphazoline—Tension—Salbutamol—chronic obstructive pulmonary disease	0.00777	0.0117	CcSEcCtD
Naphazoline—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.0077	0.0116	CcSEcCtD
Naphazoline—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.00724	0.0109	CcSEcCtD
Naphazoline—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.00724	0.0109	CcSEcCtD
Naphazoline—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00706	0.0106	CcSEcCtD
Naphazoline—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.00706	0.0106	CcSEcCtD
Naphazoline—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.00684	0.0103	CcSEcCtD
Naphazoline—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00666	0.01	CcSEcCtD
Naphazoline—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.00625	0.0094	CcSEcCtD
Naphazoline—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.00609	0.00915	CcSEcCtD
Naphazoline—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.00609	0.00915	CcSEcCtD
Naphazoline—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.00596	0.00896	CcSEcCtD
Naphazoline—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00595	0.00894	CcSEcCtD
Naphazoline—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.00575	0.00864	CcSEcCtD
Naphazoline—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00564	0.00847	CcSEcCtD
Naphazoline—Propranolol—ADRB2—chronic obstructive pulmonary disease	0.00561	0.102	CrCbGaD
Naphazoline—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00561	0.00844	CcSEcCtD
Naphazoline—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00534	0.00803	CcSEcCtD
Naphazoline—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00532	0.00799	CcSEcCtD
Naphazoline—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00504	0.00758	CcSEcCtD
Naphazoline—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.00491	0.00739	CcSEcCtD
Naphazoline—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.00491	0.00739	CcSEcCtD
Naphazoline—Propranolol—CYP1A1—chronic obstructive pulmonary disease	0.00481	0.0877	CrCbGaD
Naphazoline—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.00481	0.00723	CcSEcCtD
Naphazoline—Propranolol—CYP1A2—chronic obstructive pulmonary disease	0.00464	0.0846	CrCbGaD
Naphazoline—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.00464	0.00697	CcSEcCtD
Naphazoline—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.00454	0.00683	CcSEcCtD
Naphazoline—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00453	0.00681	CcSEcCtD
Naphazoline—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00453	0.00681	CcSEcCtD
Naphazoline—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00444	0.00667	CcSEcCtD
Naphazoline—Headache—Formoterol—chronic obstructive pulmonary disease	0.00429	0.00645	CcSEcCtD
Naphazoline—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00429	0.00645	CcSEcCtD
Naphazoline—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.00428	0.00644	CcSEcCtD
Naphazoline—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.00428	0.00643	CcSEcCtD
Naphazoline—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.00428	0.00643	CcSEcCtD
Naphazoline—Headache—Montelukast—chronic obstructive pulmonary disease	0.0042	0.00632	CcSEcCtD
Naphazoline—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00407	0.00612	CcSEcCtD
Naphazoline—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00407	0.00612	CcSEcCtD
Naphazoline—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00405	0.00609	CcSEcCtD
Naphazoline—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00398	0.00599	CcSEcCtD
Naphazoline—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.00392	0.0059	CcSEcCtD
Naphazoline—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00384	0.00577	CcSEcCtD
Naphazoline—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.00382	0.00575	CcSEcCtD
Naphazoline—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.00359	0.00539	CcSEcCtD
Naphazoline—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.00355	0.00533	CcSEcCtD
Naphazoline—Erythema—Prednisone—chronic obstructive pulmonary disease	0.0033	0.00496	CcSEcCtD
Naphazoline—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.00311	0.00468	CcSEcCtD
Naphazoline—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.00285	0.00429	CcSEcCtD
Naphazoline—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.00278	0.00418	CcSEcCtD
Naphazoline—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.00261	0.00392	CcSEcCtD
Naphazoline—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.00245	0.00369	CcSEcCtD
Naphazoline—Headache—Prednisolone—chronic obstructive pulmonary disease	0.00232	0.00349	CcSEcCtD
Naphazoline—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.0022	0.00331	CcSEcCtD
Naphazoline—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.00193	0.00291	CcSEcCtD
Naphazoline—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.00178	0.00268	CcSEcCtD
Naphazoline—Headache—Prednisone—chronic obstructive pulmonary disease	0.00169	0.00254	CcSEcCtD
Naphazoline—Nausea—Prednisone—chronic obstructive pulmonary disease	0.0016	0.00241	CcSEcCtD
Naphazoline—ADRA2A—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.000682	0.00244	CbGpPWpGaD
Naphazoline—ADRA2B—Hemostasis—TGFB2—chronic obstructive pulmonary disease	0.000682	0.00244	CbGpPWpGaD
Naphazoline—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—chronic obstructive pulmonary disease	0.000664	0.00237	CbGpPWpGaD
Naphazoline—ADRA2C—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.000656	0.00235	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.000656	0.00234	CbGpPWpGaD
Naphazoline—ADRA2C—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.000643	0.0023	CbGpPWpGaD
Naphazoline—ADRA2C—Hemostasis—TGFB2—chronic obstructive pulmonary disease	0.000637	0.00227	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—APIP—chronic obstructive pulmonary disease	0.000636	0.00227	CbGpPWpGaD
Naphazoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.000629	0.00225	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000625	0.00223	CbGpPWpGaD
Naphazoline—ADRA1A—AMPK Signaling—TP53—chronic obstructive pulmonary disease	0.000625	0.00223	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.000612	0.00219	CbGpPWpGaD
Naphazoline—ADRA2B—Hemostasis—HDAC2—chronic obstructive pulmonary disease	0.000611	0.00218	CbGpPWpGaD
Naphazoline—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.000602	0.00215	CbGpPWpGaD
Naphazoline—ADRA2A—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	0.000596	0.00213	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000595	0.00213	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.000587	0.0021	CbGpPWpGaD
Naphazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.000584	0.00209	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000581	0.00208	CbGpPWpGaD
Naphazoline—ADRA2B—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	0.00058	0.00207	CbGpPWpGaD
Naphazoline—ADRA2B—Platelet activation, signaling and aggregation—ALB—chronic obstructive pulmonary disease	0.000579	0.00207	CbGpPWpGaD
Naphazoline—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.000574	0.00205	CbGpPWpGaD
Naphazoline—ADRA2C—Hemostasis—HDAC2—chronic obstructive pulmonary disease	0.000571	0.00204	CbGpPWpGaD
Naphazoline—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.000562	0.00201	CbGpPWpGaD
Naphazoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.000562	0.00201	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000556	0.00199	CbGpPWpGaD
Naphazoline—ADRA2B—Hemostasis—PLAUR—chronic obstructive pulmonary disease	0.000551	0.00197	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.000548	0.00196	CbGpPWpGaD
Naphazoline—ADRA2C—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	0.000542	0.00194	CbGpPWpGaD
Naphazoline—ADRA2C—Platelet activation, signaling and aggregation—ALB—chronic obstructive pulmonary disease	0.000541	0.00193	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.000535	0.00191	CbGpPWpGaD
Naphazoline—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.000533	0.00191	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.000528	0.00189	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.000524	0.00187	CbGpPWpGaD
Naphazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.000522	0.00187	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000518	0.00185	CbGpPWpGaD
Naphazoline—ADRA2A—Hemostasis—TGFB2—chronic obstructive pulmonary disease	0.000517	0.00185	CbGpPWpGaD
Naphazoline—ADRA2C—Hemostasis—PLAUR—chronic obstructive pulmonary disease	0.000515	0.00184	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—GC—chronic obstructive pulmonary disease	0.000504	0.0018	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.000497	0.00178	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.000494	0.00176	CbGpPWpGaD
Naphazoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.000492	0.00176	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.00049	0.00175	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000486	0.00174	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.00048	0.00171	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.000479	0.00171	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000469	0.00167	CbGpPWpGaD
Naphazoline—ADRA2B—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	0.000468	0.00167	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000464	0.00166	CbGpPWpGaD
Naphazoline—ADRA2A—Hemostasis—HDAC2—chronic obstructive pulmonary disease	0.000464	0.00166	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.000459	0.00164	CbGpPWpGaD
Naphazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.000457	0.00163	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000452	0.00161	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.000448	0.0016	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.000445	0.00159	CbGpPWpGaD
Naphazoline—ADRA2A—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	0.00044	0.00157	CbGpPWpGaD
Naphazoline—ADRA2A—Platelet activation, signaling and aggregation—ALB—chronic obstructive pulmonary disease	0.000439	0.00157	CbGpPWpGaD
Naphazoline—ADRA2C—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	0.000437	0.00156	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000433	0.00155	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.000431	0.00154	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.000428	0.00153	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.000428	0.00153	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000421	0.0015	CbGpPWpGaD
Naphazoline—ADRA2A—Hemostasis—PLAUR—chronic obstructive pulmonary disease	0.000418	0.00149	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—GC—chronic obstructive pulmonary disease	0.00041	0.00146	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.000401	0.00143	CbGpPWpGaD
Naphazoline—ADRA2B—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	0.000399	0.00143	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.000398	0.00142	CbGpPWpGaD
Naphazoline—ADRA2B—Hemostasis—MMP1—chronic obstructive pulmonary disease	0.000394	0.00141	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.000392	0.0014	CbGpPWpGaD
Naphazoline—ADRA2B—Hemostasis—PLAU—chronic obstructive pulmonary disease	0.000387	0.00138	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000381	0.00136	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000379	0.00135	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.000374	0.00134	CbGpPWpGaD
Naphazoline—ADRA2C—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	0.000373	0.00133	CbGpPWpGaD
Naphazoline—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	0.000372	0.00133	CbGpPWpGaD
Naphazoline—ADRA2C—Hemostasis—MMP1—chronic obstructive pulmonary disease	0.000368	0.00131	CbGpPWpGaD
Naphazoline—ADRA2B—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	0.000366	0.00131	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.000364	0.0013	CbGpPWpGaD
Naphazoline—ADRA2C—Hemostasis—PLAU—chronic obstructive pulmonary disease	0.000361	0.00129	CbGpPWpGaD
Naphazoline—ADRA2B—Hemostasis—NOS2—chronic obstructive pulmonary disease	0.000355	0.00127	CbGpPWpGaD
Naphazoline—ADRA2A—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	0.000355	0.00127	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000352	0.00126	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000352	0.00126	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.000348	0.00124	CbGpPWpGaD
Naphazoline—ADRA2C—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	0.000347	0.00124	CbGpPWpGaD
Naphazoline—ADRA2C—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	0.000342	0.00122	CbGpPWpGaD
Naphazoline—ADRA2C—Hemostasis—NOS2—chronic obstructive pulmonary disease	0.000332	0.00119	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.000331	0.00118	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000328	0.00117	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.00031	0.00111	CbGpPWpGaD
Naphazoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	0.000304	0.00109	CbGpPWpGaD
Naphazoline—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	0.000303	0.00108	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.000301	0.00108	CbGpPWpGaD
Naphazoline—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	0.0003	0.00107	CbGpPWpGaD
Naphazoline—ADRA2B—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	0.000299	0.00107	CbGpPWpGaD
Naphazoline—ADRA2A—Hemostasis—MMP1—chronic obstructive pulmonary disease	0.000299	0.00107	CbGpPWpGaD
Naphazoline—ADRA2B—Hemostasis—ALB—chronic obstructive pulmonary disease	0.000299	0.00107	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.000296	0.00106	CbGpPWpGaD
Naphazoline—ADRA2A—Hemostasis—PLAU—chronic obstructive pulmonary disease	0.000293	0.00105	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000287	0.00103	CbGpPWpGaD
Naphazoline—ADRA2B—Hemostasis—NOS3—chronic obstructive pulmonary disease	0.000286	0.00102	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000283	0.00101	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	0.000283	0.00101	CbGpPWpGaD
Naphazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	0.000282	0.00101	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.000281	0.001	CbGpPWpGaD
Naphazoline—ADRA2C—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	0.000279	0.000998	CbGpPWpGaD
Naphazoline—ADRA2C—Hemostasis—ALB—chronic obstructive pulmonary disease	0.000279	0.000996	CbGpPWpGaD
Naphazoline—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	0.000278	0.000993	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.000277	0.000989	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000275	0.000984	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000272	0.000973	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.000271	0.000967	CbGpPWpGaD
Naphazoline—ADRA2A—Hemostasis—NOS2—chronic obstructive pulmonary disease	0.00027	0.000963	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.000269	0.000961	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000267	0.000953	CbGpPWpGaD
Naphazoline—ADRA2C—Hemostasis—NOS3—chronic obstructive pulmonary disease	0.000267	0.000953	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000265	0.000946	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	0.000265	0.000945	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.000259	0.000926	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.000251	0.000898	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.000251	0.000898	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000248	0.000888	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.000246	0.000878	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.000242	0.000865	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.000242	0.000864	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.000235	0.000841	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000231	0.000827	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	0.000231	0.000826	CbGpPWpGaD
Naphazoline—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	0.00023	0.000823	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000229	0.000818	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.000228	0.000816	CbGpPWpGaD
Naphazoline—ADRA2A—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	0.000227	0.000811	CbGpPWpGaD
Naphazoline—ADRA2A—Hemostasis—ALB—chronic obstructive pulmonary disease	0.000227	0.000809	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.000225	0.000803	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000224	0.000799	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000221	0.00079	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.00022	0.000785	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.00022	0.000785	CbGpPWpGaD
Naphazoline—ADRA2A—Hemostasis—NOS3—chronic obstructive pulmonary disease	0.000217	0.000774	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000215	0.000768	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	0.000215	0.000768	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.000212	0.000756	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000207	0.00074	CbGpPWpGaD
Naphazoline—ADRA2B—Hemostasis—VEGFA—chronic obstructive pulmonary disease	0.000206	0.000735	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.000204	0.000729	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000202	0.000721	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.000197	0.000702	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000194	0.000692	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.000193	0.000688	CbGpPWpGaD
Naphazoline—ADRA2C—Hemostasis—VEGFA—chronic obstructive pulmonary disease	0.000192	0.000687	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.000192	0.000686	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000191	0.000682	CbGpPWpGaD
Naphazoline—ADRA2B—Hemostasis—TGFB1—chronic obstructive pulmonary disease	0.000189	0.000675	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000188	0.000673	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000186	0.000664	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.00018	0.000643	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.000179	0.000638	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.000178	0.000635	CbGpPWpGaD
Naphazoline—ADRA2C—Hemostasis—TGFB1—chronic obstructive pulmonary disease	0.000176	0.00063	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000175	0.000627	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000169	0.000605	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000166	0.000594	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.000166	0.000593	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	0.00016	0.000572	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	0.000159	0.000568	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.000157	0.000562	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000157	0.000562	CbGpPWpGaD
Naphazoline—ADRA2A—Hemostasis—VEGFA—chronic obstructive pulmonary disease	0.000156	0.000558	CbGpPWpGaD
Naphazoline—ADRA2B—Hemostasis—TP53—chronic obstructive pulmonary disease	0.000155	0.000555	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000155	0.000554	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000153	0.000546	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	0.00015	0.000534	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	0.000148	0.00053	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.000146	0.000522	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	0.000145	0.000519	CbGpPWpGaD
Naphazoline—ADRA2C—Hemostasis—TP53—chronic obstructive pulmonary disease	0.000145	0.000519	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.000145	0.000519	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	0.000144	0.000516	CbGpPWpGaD
Naphazoline—ADRA2A—Hemostasis—TGFB1—chronic obstructive pulmonary disease	0.000143	0.000512	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000143	0.000509	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	0.000139	0.000497	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	0.000136	0.000485	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000135	0.000483	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	0.000135	0.000482	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.000135	0.000482	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	0.000131	0.000467	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	0.00013	0.000464	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	0.00013	0.000464	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—LEP—chronic obstructive pulmonary disease	0.000129	0.000462	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	0.000121	0.000434	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—LEP—chronic obstructive pulmonary disease	0.000121	0.000431	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	0.000121	0.000431	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	0.000119	0.000424	CbGpPWpGaD
Naphazoline—ADRA2A—Hemostasis—TP53—chronic obstructive pulmonary disease	0.000118	0.000421	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	0.000118	0.000421	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	0.000114	0.000406	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—ALB—chronic obstructive pulmonary disease	0.000113	0.000404	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	0.00011	0.000394	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	0.00011	0.000391	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—NOS3—chronic obstructive pulmonary disease	0.000108	0.000386	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	0.000106	0.00038	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	0.000106	0.000377	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	0.000105	0.000377	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	0.000101	0.000362	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	9.93e-05	0.000355	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	9.8e-05	0.00035	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	9.68e-05	0.000346	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	9.47e-05	0.000338	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—ALB—chronic obstructive pulmonary disease	9.18e-05	0.000328	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	9.04e-05	0.000323	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—NOS3—chronic obstructive pulmonary disease	8.78e-05	0.000314	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	8.68e-05	0.00031	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	8.59e-05	0.000307	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	8.28e-05	0.000296	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	8.17e-05	0.000292	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	8.06e-05	0.000288	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	8.02e-05	0.000287	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	7.91e-05	0.000282	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	7.77e-05	0.000278	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	7.69e-05	0.000275	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	7.63e-05	0.000273	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	7.35e-05	0.000262	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	7.26e-05	0.000259	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	7.01e-05	0.000251	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	6.97e-05	0.000249	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	6.67e-05	0.000238	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	6.52e-05	0.000233	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	6.52e-05	0.000233	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	6.4e-05	0.000229	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	6.34e-05	0.000227	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	6.28e-05	0.000224	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	6.2e-05	0.000221	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.98e-05	0.000214	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.89e-05	0.000211	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.86e-05	0.000209	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.7e-05	0.000203	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.29e-05	0.000189	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	5.27e-05	0.000188	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.23e-05	0.000187	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.13e-05	0.000183	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.92e-05	0.000176	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.86e-05	0.000174	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.82e-05	0.000172	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.76e-05	0.00017	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.51e-05	0.000161	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.3e-05	0.000154	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4e-05	0.000143	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.94e-05	0.000141	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.66e-05	0.000131	CbGpPWpGaD
